Why No One Can Look Away From Elizabeth Holmes
“I felt like there were some moments in the film where she was just brazenly lying.”
The fascination with Elizabeth Holmes, the founder of the now-defunct health technology company Theranos, continues to captivate the public's attention. This is largely due to the sheer audacity and brazenness of her actions, as evident in the film where she is seen blatantly lying. The fact that someone could so callously deceive investors, customers, and even her own employees has sparked a mix of outrage and morbid curiosity.
The Theranos scandal has significant implications for the tech and healthcare industries, highlighting the dangers of unchecked ambition and the importance of rigorous oversight. Holmes' ability to charm and deceive high-profile investors and partners has raised questions about the due diligence process and the willingness of some to turn a blind eye to red flags in pursuit of the next big thing. As the story continues to unfold, it serves as a cautionary tale for entrepreneurs, investors, and regulators alike.
As the public continues to grapple with the complexities of the Theranos scandal, it will be interesting to watch how the story evolves and what lessons are ultimately learned from it. Will there be greater scrutiny of startup culture and the pressure to succeed at all costs? How will the scandal impact the development of health technology and the regulation of the industry? As more information comes to light, it is likely that the fascination with Elizabeth Holmes will only continue to grow, serving as a reminder of the importance of accountability and ethics in business and technology.
Originally reported by nytimes.com. MyNews adds analysis for general news readers.